Nonprofits›Regents Of The University Of Colorado
Education
Regents Of The University Of Colorado
DENVER, CO
Total revenue
—
Total expenses
—
Net assets
—
Grants received
$1.5B
1,645 grants
EIN
846000555
Tax year
—
Grants received
Showing 200 of 1,645
FromAmountPurposeYear
$1M
TO UNDERSTAND MOLECULAR VULNERABILITIES IN CELLS THAT PRODUCE LARGE AMOUNTS OF A SINGLE PROTEIN
2024
$638K
To study and coordinate the use of research among districts participating in Wallace's ECPI.
2024
$421K
TO DEVELOP IMPROVED METHODOLOGY AND HIGH-SPEED IMAGERY TO VISUALIZE LIQUID-SOLID SUSPENSIONS, AND THE INTERACTIONS BETWEEN THE SOLID PARTICLE PHASE AND THE LIQUID CARRIER, IN UNPRECEDENTED DETAIL.
2024
$393K
TO STUDY THE LOW-TEMPERATURE BEHAVIORS OF THE FERMI-HUBBARD MODEL BY PROBING ULTRACOLD GASES AT THE SINGLE-ATOM LEVEL IN AN EXTREME LOW-HEATING ENVIRONMENT.
2024
$385K
SUPPORT FOR COMMUNITY-BASED RISK REDUCTION AND EMERGENCY READINESS
2024
$320K
IN SUPPORT OF INVESTIGATIONS OF STRONGLY CORRELATED AND TOPOLOGICAL MATERIALS USING LOW-TEMPERATURE ANGLE-RESOLVED PHOTOEMISSION SPECTROSCOPY.
2024
$300K
DEVELOPING A MODEL OF TEACHER LEARNING TO SUPPORT COMPUTATIONALLY RICH COMMUNICATION IN SCIENCE CLASSROOMS
2024
$299K
EMBEDDING RESEARCH INTO ORGANIZATIONAL ROUTINES TO DEEPEN THE USE OF EVIDENCE
2024
$242K
TO SUPPORT A RANDOMIZED CONTROLLED TRIAL TO EVALUATE LIFESKILLS TRAINING PROGRAM FOR HIGH SCHOOL STUDENTS IN COLORADO.
2024
$200K
Innovative Clinical or Translational Science Health Disparities
2024
$200K
Innovative Research to Improve the Lives of Women with Diabetes Across the Lifespan
2024
$200K
Innovative Clinical or Translational Science Precision Medicine
2024
$195K
Innovative Research to Tackle the Epidemic of Youth-Onset Type 2 Diabetes
2024
$140K
IMPROVING OUTCOMES AND EQUITY THROUGH TARGETED SCREENING FOR EOSINOPHILIC ESOPHAGITIS
2024
$140K
IMPROVING OUTCOMES AND EQUITY THROUGH TARGETED SCREENING FOR EOSINOPHILIC ESOPHAGITIS
2024
$136K
TO IDENTIFY STATE POLICY LEVERS THAT HELP ADVANCE ADOPTION OF PRIMARY CARE ALTERNATIVE PAYMENT MODELS AND FACILITATE GREAT MULTI-PAYER ALIGNMENT AND ASSESSING EARLY USE OF SUCH LEVERS.
2024
$135K
TO SUPPORT THE ADMINISTRATION OF THE BLUEPRINTS FOR HEALTHY YOUTH DEVELOPMENT INITIATIVE, AN ONLINE REGISTRY OF EVIDENCE-BASED PROGRAMS IN YOUTH DEVELOPMENT.
2024
$130K
Innovative Research to Tackle the Epidemic of Youth-Onset Type 2 Diabetes
2024
$120K
DIAGNOSIS-SPECIFIC IMMERSIVE VIRTUAL REALITY APPLICATION DEVELOPMENT FOR THE MODULATION OF DEPRESSIVE AND ANXIETY SYMPTOMS IN CHILDREN WITH SEVERE TINNITUS
2024
$92K
IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
2024
$90K
Support development and uptake of a wellness measure for Native American youth and young adults 16-24
2024
$75K
Mental health programming, holocaust genocide and contemporary bioethics lecture
2024
$75K
Current precision therapeutic clinical trials for Dravet syndrome (DS) utilize seizure frequency as the primary outcome measure, but using this alone to assess outcome does not capture the full array of challenges associated with DS. This project will focus on refining a set of clinician and caregiver-reported outcome measures previously created for CDKL5-deficiency disorder and piloting them in patients with DS. The overarching objective is to design valid and feasible outcome measures specifically for DS that represent the full range of the phenotype. The creation of the DS clinical severity assessment-clinician and caregiver (DS-CSA) will be a crucial step towards disease modifying clinical trial readiness in DS.
2024
$53K
TO CONDUCT RESEARCH BY USING MEDICARE ADVANTAGE ENCOUNTER DATA AND TRADITIONAL MEDICARE CLAIMS TO DEVELOP A PROCESS TO INCLUDE MEDICARE ADVANTAGE DATA IN THE CALCULATION OF INFLATION REBATES FOR PART B DRUGS, WITH THE ULTIMATE GOAL OF PROVIDING TECHNICAL GUIDANCE TO CENTERS FOR MEDICARE & MEDICAID SERVICES TO IMPROVE THE IMPLEMENTATION OF REBATE CALCULATIONS UNDER THE INFLATION REDUCTION ACT FOR PART B DRUGS.
2024
$49K
Illuminating the Late Cretaceous (ca. 68 - 74 million-year-old) mammals and other tiny vertebrates of Colorado's Western Slope through discovery and study of microvertebrate sites in the Williams Fork Formation
2024
$45K
TO FUND A FOLLOW-UP RANDOMIZED CONTROLLED TRIAL COMPARING FULL-DAY PRESCHOOL TO HALF-DAY PRESCHOOL.
2024
$40K
INVESTIGATING THE MOLECULAR BASIS FOR THE IMPAIRED MITOCHONDRIAL DYNAMICS IN BARTH SYNDROME
2024
$35K
IMPROVING OUTCOMES AND EQUITY THROUGH TARGETED SCREENING FOR EOSINOPHILIC ESOPHAGITIS
2024
$25K
AFC - Accreditation Foundation Committee Microgrant
2024
$25K
SEED GRANT, PRE-INJURY SLEEP QUALITY AS A RISK FACTOR FOR INCREASED ALCOHOL CONSUMPTION FOLLOWING TBI
2024
$25K
DEVELOPING AN ACNE PATIENT DECISION AID WITH AND FOR HISPANIC TEENAGERS
2024
$22K
TO SUPPORT THE RECRUITMENT OF LOCAL HEALTH DEPARTMENTS FOR PH WINS
2024
$13K
2024 Quality Improvement Transition of Care Grant - $13000
2024
$10K
Support the 2024 International Virtual Conference: A Call to Action to Change Child Welfare from October 7-10, 2024
2024
$8K
Johnson depression center, firearm injury prevention initiative fund
2024
$5K
TO SUPPORT A RANDOMIZED CONTROLLED TRIAL OF INSIDETRACK, A COACHING AND MENTORING PROGRAM FOR RECENT COLLEGE DROPOUTS DESIGNED TO INCREASE COLLEGE RE-ENROLLMENT AND COMPLETION.
2024
Funded by
$1.5B from 513 funders · 1,645 grants · 2016–2024
University Of Colorado Foundation
$803.9M · 4 grants · 2020–2024
Pac-12 Conference
$216.5M · 7 grants · 2017–2023
Johns Hopkins University
$46.9M · 8 grants · 2017–2023
University Of Colorado Property
$36.2M · 1 grant · 2019
Poudre Valley Health Care Inc
$35.4M · 8 grants · 2017–2023
Medical Center Of The Rockies
$28.0M · 8 grants · 2017–2023
Cystic Fibrosis Foundation
$17.5M · 52 grants · 2018–2024
American Heart Association Inc
$16.9M · 8 grants · 2018–2023
Details
EIN846000555
NTEE codeB40
Subsection03
Ruling date1939-10